The head of the Pharmaceutical Chamber of the Federation of Egyptian Industries, Gamal El-Leithy, shares his view on the positive developments driving the growth of Egypt’s pharma market, including the creation of an independent regulatory body and a procurement agency. In addition, he analyses the country’s response to the COVID-19 pandemic, the strength of Egypt’s pharma manufacturing base, and the challenging pricing system.
We are very proud of Egypt as a country and of how the authorities handled the COVID-19 crisis. We did not experience any shortages of medicines, food or other commodities. Most of the pharmaceutical companies were eager to continue producing in spite of an increase in costs.